Wednesday, June 10, 2026

Drug profile · INN

polatuzumab

polatuzumab is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — polatuzumab
Class
Route
Patents
0
Programs
3
Data quality
0.70